{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:28:44Z","timestamp":1786786124105,"version":"build-2736575974"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07209-4","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:28:00Z","timestamp":1785313680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reinterpreting the matched-sibling relapse penalty in ATG-based allogeneic transplantation for myelodysplastic neoplasms: a question of dose, not donor"],"prefix":"10.1007","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4426-9434","authenticated-orcid":false,"given":"Naif I.","family":"AlJohani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"7209_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00277-026-06999-x","volume":"105","author":"SY Park","year":"2026","unstructured":"Park SY, Lee H, Kwag D et al (2026) Donor type and post-transplant outcomes in anti-thymocyte globulin based allogeneic transplantation for myelodysplastic syndromes. Ann Hematol 105:260. https:\/\/doi.org\/10.1007\/s00277-026-06999-x","journal-title":"Ann Hematol"},{"issue":"6","key":"7209_CR2","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41409-020-0792-x","volume":"55","author":"F Bonifazi","year":"2020","unstructured":"Bonifazi F, Rubio MT, Bacigalupo A et al (2020) Rabbit ATG\/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel. Bone Marrow Transpl 55(6):1093\u20131102. https:\/\/doi.org\/10.1038\/s41409-020-0792-x","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"7209_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41409-017-0043-y","volume":"53","author":"R Devillier","year":"2018","unstructured":"Devillier R, Labopin M, Chevallier P et al (2018) Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transpl 53(4):431\u2013437. https:\/\/doi.org\/10.1038\/s41409-017-0043-y","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"7209_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00277-019-03884-8","volume":"99","author":"L Dou","year":"2020","unstructured":"Dou L, Hou C, Ma C et al (2020) Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies. Ann Hematol 99(1):167\u2013179. https:\/\/doi.org\/10.1007\/s00277-019-03884-8","journal-title":"Ann Hematol"},{"issue":"8","key":"7209_CR5","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/bmt.2011.225","volume":"47","author":"F Bonifazi","year":"2012","unstructured":"Bonifazi F, Bandini G, Arpinati M et al (2012) Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis. Bone Marrow Transpl 47(8):1105\u20131111. https:\/\/doi.org\/10.1038\/bmt.2011.225","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"7209_CR6","doi-asserted-by":"publisher","first-page":"e0284476","DOI":"10.1371\/journal.pone.0284476","volume":"18","author":"J Zuckermann","year":"2023","unstructured":"Zuckermann J, de Castro BM, Cunha TA, Paz A, Moreira LB (2023) Systematic review and meta-analysis of anti-thymocyte globulin dosage as a component of graft-versus-host disease prophylaxis. PLoS ONE 18(4):e0284476. https:\/\/doi.org\/10.1371\/journal.pone.0284476","journal-title":"PLoS ONE"},{"issue":"25","key":"7209_CR7","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1182\/blood-2011-01-332007","volume":"117","author":"RJ Soiffer","year":"2011","unstructured":"Soiffer RJ, LeRademacher J, Ho V et al (2011) Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Blood 117(25):6963\u20136970. https:\/\/doi.org\/10.1182\/blood-2011-01-332007","journal-title":"Blood"},{"issue":"2","key":"7209_CR8","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/S2352-3026(18)30214-X","volume":"6","author":"F Bonifazi","year":"2019","unstructured":"Bonifazi F, Solano C, Wolschke C et al (2019) Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomized study. Lancet Haematol 6(2):e89\u2013e99. https:\/\/doi.org\/10.1016\/S2352-3026(18)30214-X","journal-title":"Lancet Haematol"},{"issue":"1","key":"7209_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1506002","volume":"374","author":"N Kr\u00f6ger","year":"2016","unstructured":"Kr\u00f6ger N, Solano C, Wolschke C et al (2016) Antilymphocyte globulin for prevention of chronic graft-versus-host disease. N Engl J Med 374(1):43\u201353. https:\/\/doi.org\/10.1056\/NEJMoa1506002","journal-title":"N Engl J Med"},{"issue":"5","key":"7209_CR10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41409-022-01620-x","volume":"57","author":"E Forcade","year":"2022","unstructured":"Forcade E, Chevret S, Finke J et al (2022) Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transpl 57(5):768\u2013774. https:\/\/doi.org\/10.1038\/s41409-022-01620-x","journal-title":"Bone Marrow Transpl"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07209-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07209-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07209-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:20:21Z","timestamp":1786785621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07209-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":10,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7209"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07209-4","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This Matters Arising piece is a post-publication scientific commentary and does not involve human or animal participants, data, or biological material.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"350"}}